The groundbreaking therapy of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in greater glucose https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment